Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Carcinogenesis|November 16, 2020
ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylationKoji Kase, Motonobu Saito, Shotaro Nakajima, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2023
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapyMasayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi, et al.
Oncology Letters|August 10, 2023
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapyRyotaro Ohkuma, Yuki Fujimoto, Katsuaki Ieguchi, et al.
Frontiers in Immunology|September 24, 2025
Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
Frontiers in Immunology|April 13, 2026
Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
Gynecologic Oncology|November 24, 2019
Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patientsSou Hirose, Naoya Murakami, Kazuaki Takahashi, et al.
Anticancer Research|December 30, 2023
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse ModelTsubasa Goshima, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Frontiers in Immunology|October 4, 2023
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitorsRyotaro Ohkuma, Sakiko Miura, Satoshi Muto, et al.
Pageof 4